Literature DB >> 9655045

The role of IL-6 in the pathogenesis of periodontal disease.

C R Irwin1, T T Myrillas.   

Abstract

The mechanisms underlying periodontal disease involve complex interactions between bacterial products, host cells and locally produced, biologically active factors. The umbrella term cytokine has been used to include a variety of such factors, including the interleukin family. The role of one cytokine, IL-1 beta, in periodontal disease pathogenesis has been widely reported. More recent studies have focused on a potential role for IL-6 in driving the destructive processes. Most of these reports have suggested a pro-inflammatory role for IL-6 alongside IL-1 and TNF-alpha. This manuscript reviews the biological functions of IL-6, specifically related to tissue destruction at the periodontal site. We would suggest that the activity of IL-6 in periodontal disease differs from IL-1 and TNF-alpha, and may, in part, play a protective role.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655045     DOI: 10.1111/j.1601-0825.1998.tb00255.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  34 in total

1.  Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion.

Authors:  A Lourbakos; J Potempa; J Travis; M R D'Andrea; P Andrade-Gordon; R Santulli; E J Mackie; R N Pike
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.

Authors:  W Chen; B Gao; L Hao; G Zhu; J Jules; M J MacDougall; J Wang; X Han; X Zhou; Y-P Li
Journal:  J Periodontal Res       Date:  2016-01-11       Impact factor: 4.419

3.  Calcitriol Suppressed Inflammatory Reactions in IL-1β-Stimulated Human Periodontal Ligament Cells.

Authors:  Yoshitaka Hosokawa; Ikuko Hosokawa; Satoru Shindo; Kazumi Ozaki; Takashi Matsuo
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

Review 4.  Emerging horizons of salivary diagnostics for periodontal disease.

Authors:  L Fuentes; M Yakob; D T W Wong
Journal:  Br Dent J       Date:  2014-11       Impact factor: 1.626

Review 5.  B cells as under-appreciated mediators of non-auto-immune inflammatory disease.

Authors:  Barbara S Nikolajczyk
Journal:  Cytokine       Date:  2010-04-10       Impact factor: 3.861

6.  Expression of periodontal interleukin-6 protein is increased across patients with neither periodontal disease nor diabetes, patients with periodontal disease alone and patients with both diseases.

Authors:  J H Ross; D C Hardy; C A Schuyler; E H Slate; T W Mize; Y Huang
Journal:  J Periodontal Res       Date:  2010-07-29       Impact factor: 4.419

7.  Effects of methyl gallate and gallic acid on the production of inflammatory mediators interleukin-6 and interleukin-8 by oral epithelial cells stimulated with Fusobacterium nucleatum.

Authors:  Mi-Sun Kang; Hee-Sook Jang; Jong-Suk Oh; Kyu-Ho Yang; Nam-Ki Choi; Hoi-Soon Lim; Seon-Mi Kim
Journal:  J Microbiol       Date:  2010-02-04       Impact factor: 3.422

8.  Interleukin-6 expression and gene polymorphism are associated with severity of periodontal disease in a sample of Brazilian individuals.

Authors:  P R Moreira; P M A Lima; K O B Sathler; S A W Imanishi; J E Costa; R S Gomes; K J Gollob; W O Dutra
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

9.  TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients.

Authors:  Madhumita Jagannathan; Hatice Hasturk; Yanmei Liang; Hyunjin Shin; Jeremy T Hetzel; Alpdogan Kantarci; Daniel Rubin; Marie E McDonnell; Thomas E Van Dyke; Lisa M Ganley-Leal; Barbara S Nikolajczyk
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

10.  Effect of nifedipine, a calcium channel blocker, on the generation of nitric oxide and interleukin-1β by murine macrophages activated by lipopolysaccharide from Prevotella intermedia.

Authors:  So-Hui Choe; Eun-Young Choi; Jin-Yi Hyeon; Bo Ram Keum; In Soon Choi; Sung-Jo Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-08-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.